β-hydroxybutyrate recapitulates the beneficial effects of ketogenic metabolic therapy in polycystic kidney disease.
Torres JA, Holznecht N, Asplund DA, Kroes BC, Amarlkhagva T, Haeffner MM, Sharpe EH, Koestner S, Strubl S, Schimmel MF, Kruger S, Agrawal S, Aceves BA, Thangaraju M, Weimbs T.
Torres JA, et al. Among authors: kruger s.
iScience. 2024 Aug 20;27(9):110773. doi: 10.1016/j.isci.2024.110773. eCollection 2024 Sep 20.
iScience. 2024.
PMID: 39314240
Free PMC article.